from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/government-partners-charity-breast-checking-2026a100112x
via IFTTT
Laparoscopic Radiofrequency Ablation and Myomectomy May Both Improve Symptoms of Fibroids Over 2 Years
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/laparoscopic-radiofrequency-ablation-and-myomectomy-may-both-2026a100112r
via IFTTT
Hypertension Linked to Faster Progression of Frailty
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/hypertension-linked-faster-progression-frailty-2026a100111y
via IFTTT
‘Wild West’: Cancer Drug Advances Are Creating Data Gaps
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/wild-west-cancer-drug-advances-are-creating-data-gaps-2026a1001104
via IFTTT
Psychotherapy for Major Depressive Disorder Tied to Lower Cancer Mortality Risk
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/psychotherapy-major-depressive-disorder-tied-lower-cancer-2026a10010za
via IFTTT
Metformin in Pregnancy Poses No Child Neuro Risk
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/metformin-pregnancy-poses-no-child-neuro-risk-2026a10010xl
via IFTTT
Fast Five Quiz: Female Sexual Dysfunction and Dyspareunia
from Ob/Gyn & Women’s Health – Medscape https://reference.medscape.com/viewarticle/fast-five-quiz-painful-sexual-intercourse-2025a1000e1c
via IFTTT
Experts Urge Defense Against AI Cyberattacks on Healthcare
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/experts-urge-defense-against-ai-cyberattacks-healthcare-2026a10010x0
via IFTTT
Five Bloating Mechanisms: Are You Treating the Right One?
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/five-bloating-mechanisms-are-you-treating-right-one-2026a10010ef
via IFTTT
In Phase 2 Trial, Daxdilimab Reduces Disease Activity in Moderate-to-Severe Discoid Lupus
from Ob/Gyn & Women’s Health – Medscape https://www.medscape.com/viewarticle/phase-2-trial-daxdilimab-reduces-disease-activity-moderate-2026a10010wt
via IFTTT